Atherosclerosis vaccine (AVANT Immunotherapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtherosclerosis vaccine (AVANT Immunotherapeutics)
Drug Alias NameCETP vaccine - AVANTCETi-1Cholesteryl ester transfer protein vaccine - AVANT
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvant Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvant Immunotherapeutics
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A